RLMD Competitors & Alternatives
Compare Relmada Therapeutics Inc with similar stocks in the same industry
Biotechnology
RLMD
Main Stock$4.63
Tradestie Score
48
Market Cap
$71.69M
Analyst Upside
+173.6%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VSTM
Verastem, Inc.
|
$6.89
|
$541.60M | - | 41 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$14.46
|
$540.97M | - | 48 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$11.87
|
$529.35M | 12.4 | 45 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$107.72
|
$522.78M | - | 47 | Compare |
|
MPLT
MPLT
|
$11.21
|
$520.82M | - | 52 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.30
|
$512.39M | - | 40 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$45.89
|
$505.12M | 2.5 | 33 | Compare |
|
FULC
Fulcrum Therapeutics, Inc. Common Stock
|
$3.83
|
$504.67M | - | 44 | Compare |
|
RGNX
REGENXBIO Inc.
|
$10.72
|
$493.52M | - | 41 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$103.63
|
$492.21M | - | 39 | Compare |
More RLMD Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
239 stocks in this industry